» Authors » Arun Elangovan

Arun Elangovan

Explore the profile of Arun Elangovan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 111
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Joseph K, Al Habsi Z, Abraham A, Elangovan A, Ghosh S, Pham T, et al.
Radiother Oncol . 2024 Mar; 196:110219. PMID: 38479443
Purpose: We report the impact of 1 vs. 2 doses of mitomycin-C (MMC) based chemoradiation (CRT) on patterns of treatment failure and long-term patient outcomes in anal squamous cell carcinoma...
2.
Joseph K, Al Balushi M, Ghosh S, Stenson T, Abraham A, Elangovan A, et al.
Int J Radiat Oncol Biol Phys . 2023 May; 117(2):434-445. PMID: 37148982
Purpose: Intensity modulated radiation therapy (IMRT) has confirmed its superiority in improving acute treatment-related toxicities in anal cancer, without compromising tumor control. However, the effect of IMRT on long-term quality...
3.
Ghoshal S, Dracham C, Sundaram A, Kumar R, Bal A, Das A, et al.
Indian J Otolaryngol Head Neck Surg . 2023 Feb; 74(Suppl 3):5823-5831. PMID: 36742604
To find if an association could be established between Human Papilloma Virus (HPV) infection and oropharyngeal cancers (OPCs) in a group of patients known to be regular users of tobacco,...
4.
Dracham C, Kumar N, Kumar S, Elangovan A, Yadav B, Mavuduru R, et al.
Asian J Urol . 2022 Aug; 9(3):318-328. PMID: 36035340
Objective: Conservative approaches in muscle-invasive bladder cancer (MIBC) have been evolved to avoid aggressive surgery, but are limited to elderly, frail, and patients medically unfit for surgery. Our study aimed...
5.
Chandran S, Elangovan A, Vijayakumar S, Kumar K
J Oral Maxillofac Pathol . 2022 Aug; 26(2):259-262. PMID: 35968168
Glomus tumors are uncommon, benign solitary tumors derived from the glomus apparatus. We report here a case of a malignant glomus tumor in an 8-year-old child presenting as a multilocular...
6.
Kumar N, Elangovan A, Madan R, Dracham C, Khosla D, Tripathi M, et al.
Clin Neurol Neurosurg . 2021 Jun; 207:106726. PMID: 34116459
Objective: Intuition into the molecular pathways of glioblastoma multiforme (GBM) has changed the diagnostic, prognostic, and therapeutic approaches. We investigated the influence of various clinical and molecular prognostic factors on...
7.
Dracham C, Khosla D, Kapoor R, Dey T, Periasamy K, Elangovan A, et al.
Tumori . 2021 May; 108(4):347-356. PMID: 33977780
Background: Primary adenoid cystic carcinomas (ACCs) of central trachea-bronchi system are rare and heterogeneous tumors. Definitive radiotherapy (RT) is the recommended treatment in surgically unresectable or incomplete resection or in...
8.
Kumar N, Madan R, Dracham C, Khosla D, Das N, Dey T, et al.
Clin Neurol Neurosurg . 2021 Jan; 202:106481. PMID: 33508649
Objective: Intracranial germ cell tumors (GCTs) are relatively rare neoplasms, representing 2-3 % of paediatric brain tumors in Western countries and 8-15 % in East Asia. Here, we discuss the...
9.
Elangovan A, Dracham C, Muddabhaktuni M, Zaidi A
Autops Case Rep . 2020 Dec; 10(4):e2020176. PMID: 33344309
Primary broad ligament carcinoma is a very rare occurrence with 28 reported cases worldwide, to date. The epidemiology, treatment strategy and prognosis are still uncertain because of the scarcity of...
10.
Kumar N, Madan R, Dracham C, Chandran V, Elangovan A, Khosla D, et al.
Rare Tumors . 2020 Dec; 12:2036361320972220. PMID: 33282160
Primary Mediastinal Germ Cell Tumor (PMGCT) is a rare and heterogeneous entity. These tumors are typically diagnosed in young adults and carry a poor prognosis. We conducted this study to...